UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060465
Receipt number R000069166
Scientific Title Assessing the elasticity of the flexor pronator muscles after pitching using ultrasound shear wave elastography
Date of disclosure of the study information 2026/01/27
Last modified on 2026/01/26 10:15:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessing the elasticity of the flexor pronator muscles after pitching using ultrasound shear wave elastography

Acronym

Assessing the elasticity of the flexor pronator muscles after pitching using ultrasound shear wave elastography

Scientific Title

Assessing the elasticity of the flexor pronator muscles after pitching using ultrasound shear wave elastography

Scientific Title:Acronym

Assessing the elasticity of the flexor pronator muscles after pitching using ultrasound shear wave elastography

Region

Japan


Condition

Condition

Ulnar collateral ligament (UCL) injury

Classification by specialty

Orthopedics Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate changes in stiffness of the forearm pronator-flexor muscle group before and after pitching and their relationships with pitching biomechanics

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in stiffness and shear wave velocity of the flexor carpi ulnaris, flexor digitorum superficialis, pronator teres, and flexor carpi radialis before and after pitching,

Key secondary outcomes

Muscle Strength Before and After Pitching and the Radioulnar Joint Distance at the Medial Collateral Ligament Attachment Site of the Elbow Joint; Evaluation of Shoulder and Elbow Joint Movement (Joint Angle, Velocity) in Pitching Motion Analysis


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

The examinee will throw 60 pitches.
SWE measurement and throwing motion analysis will be performed before and after pitching.
SWE will be measured using Aixplorer (Supersonic Imagine).
Throwing motion will be analyzed using Viper.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

45 years-old >

Gender

Male and Female

Key inclusion criteria

Athletes with overthrow movements
Subjects who, after receiving a full explanation of their participation in this study and with full understanding, have given their free written consent (or that of their surrogate in the case of minors).

Key exclusion criteria

1. Individuals with significantly poor compliance
2. Other individuals deemed unsuitable as research subjects by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshiaki
Middle name
Last name Itoigawa

Organization

Juntendo University Urayasu Hospital

Division name

Orthopedics

Zip code

2790021

Address

2-1-1 Tomioka, Urayasu, Chiba, Japan

TEL

047-353-3111

Email

yitoiga@juntendo.ac.jp


Public contact

Name of contact person

1st name Kazuki
Middle name
Last name Yoshida

Organization

Juntendo University Urayasu Hospital

Division name

Orthopedics

Zip code

2790021

Address

2-1-1 Tomioka, Urayasu, Chiba, Japan

TEL

047-353-3111

Homepage URL


Email

k.yoshida.cz@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Juntendo University Urayasu Hospital

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Urayasu Hospital

Address

2-1-1 Tomioka, Urayasu, Chiba, Japan

Tel

047-353-3111

Email

k.yoshida.cz@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 01 Month 24 Day

Date of IRB

2025 Year 01 Month 24 Day

Anticipated trial start date

2025 Year 01 Month 24 Day

Last follow-up date

2028 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 26 Day

Last modified on

2026 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069166